Daiichi Sankyo to buy 51% in Ranbaxy

Japan’s second-largest pharmaceutical company Daiichi Sankyo buys up to 51 per cent stake in Indian Ranbaxy Laboratories at Rs 737 a share.

Leave a Reply

Your email address will not be published. Required fields are marked *